Cargando…
Angiotensin-converting enzyme 2 as a potential therapeutic target for COVID-19: A review
As of August 16, 2021, there have been 207,173,086 confirmed cases and 4,361,996 deaths due to the coronavirus disease (COVID-19), and the pandemic remains a global challenge. To date, no effective and approved drugs are available for the treatment of COVID-19. Angiotensin-converting enzyme 2 (ACE2)...
Autores principales: | Singh, Bhagat, Singh, Dheer, Verma, Vinod, Yadav, Ramakant, Kumar, Raj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Xi'an Jiaotong University
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8677424/ https://www.ncbi.nlm.nih.gov/pubmed/34934510 http://dx.doi.org/10.1016/j.jpha.2021.12.003 |
Ejemplares similares
-
Angiotensin converting enzyme-2 as therapeutic target in COVID-19
por: Roshanravan, Neda, et al.
Publicado: (2020) -
Angiotensin-converting enzyme 2 and angiotensin 1–7: novel therapeutic targets
por: Jiang, Fan, et al.
Publicado: (2014) -
Angiotensin-Converting Enzyme 2 as a Therapeutic Target for Heart Failure
por: Chamsi-Pasha, Mohammed A. R., et al.
Publicado: (2013) -
Angiotensin-converting Enzyme Inhibitors: Can it be a Potential Treatment of Infantile Hemangioma
por: Gupta, Archika, et al.
Publicado: (2021) -
Angiotensin-converting enzyme 2 is a potential therapeutic target for EGFR-mutant lung adenocarcinoma
por: Yamaguchi, Miki, et al.
Publicado: (2017)